Scientific Advisors

Advisor: Wafik El-Diery, M.D., Ph.D.

Wakif El-Diery, M.D., Ph.D. is Deputy Director and Program Leader at Fox Chase Cancer Center in Philadelphia. Dr. El-Diery's research has focused on the molecular and genetic mechanisms of cancer and cellular apoptosis. He is internationally recognized as a leader in molecular oncology and genetics and has been selected and funded by the National Institutes of Health for his work in studying the biology of tumor suppressor genes and pathways. He is an editor for several leading scientific journals and has published over 100 research articles in leading scientific journals. His expertise in molecular genetics and clinical oncology are valuable in helping Morphotek steer its anti-cancer therapeutics programs and clinical studies.


Advisor: Kenneth Kinzler, Ph.D.

Kenneth W. Kinzler, Ph.D. is a Professor of Oncology at the Johns Hopkins School of Medicine. Dr. Kinzler's research has focused on the molecular basis of cancer and genome stability. Dr. Kinzler has been one of the most cited scientific researchers over the past decade. He has authored many cutting-edge scientific papers on the genetic basis of cancer, gene discovery and genome stability. Dr. Kinzler is a co-inventor of morphogenics, and his knowledge in molecular genetics is a valuable resource for Morphotek's platform technology. Participation by Dr. Kinzler as advisor does not constitute or imply endorsement by Johns Hopkins University or its affiliates.


Advisor: Bert Vogelstein, M.D.

Bert Vogelstein, M.D. is a Professor of Oncology and Pathology at the Johns Hopkins School of Medicine, and an investigator of the Howard Hughes Medical Institute. Dr. Vogelstein has been one of the most-cited researchers over the past decade and has received numerous awards for his work in studying the molecular basis of cancer. He is a member of the National Academy of Sciences. Dr. Vogelstein is a co-inventor of morphogenics, and his knowledge in the molecular basis of genetic diversity serves as a valuable resource for Morphotek's platform technology. Participation by Dr. Vogelstein as advisor does not constitute or imply endorsement by Johns Hopkins University or its affiliates.